Health Care, AI and Antitrust: Analysis and Next Steps

Start
As artificial intelligence (AI) continues to permeate the health care industry (and every other part of American life), the industry should be attentive to the risk of anticompetitive conduct arising from reliance on AI and cognizant of the watchful eyes of antitrust enforcers, including the Department of Justice (DOJ) and the Federal Trade Commission (FTC)….
By: Manatt, Phelps & Phillips, LLP
Previous Story

California Supreme Court Will Review Novel Negligence Theory for Pharmaceutical Manufacturers

Next Story

Microsoft Corporation Leads the Artificial Intelligence Industry in Bearing Liability for Third-Party Claims Against Consumers